课题基金 / 基金详情

Listeria Epitopes TCR Transgenics Antigen Sensitivity and Early Signaling

Listeria Epitopes TCR Transgenics Antigen Sensitivity and Early Signaling
李斯特菌表位 TCR 转基因抗原敏感性和早期信号传导
批准号:
7467909
负责人:
Mark Morris Davis
金额:
$36.76万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mark Morris Davis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the past 30 years or so, intensive work on T cell responses to 'model' antigens has resulted in a great deal of insight into T cell biology and function, particularly as it relates to the recognition of specific peptide-MHC complexes through the T cell receptor for antigen. Of particular relevance to this project, there is now good evidence that mature T cell blasts are sensitive to even a single molecule of an agonist (peptide-MHC) ligand and that this extraordinary sensitivity is at least in Dart achieved by the engagement of particular endogenous peptide-MHC complexes together with the agonist in triggering TCR dimerization. We now wish to extend these studies to the analysis of CD4 and CDS T cell responsiveness as different times and with different developmental stages of T cells during Listeria monocytogenes infection in mice. We particularly wish to test the hypothesis that T cells which emerge as dominant during Listeria infection do so because they have superior signaling properties. These studies will involve making a series of CD4transgenics specific for a Listeria LLO epitope and assaying these transgenic cells for sensitivity and ability to be protective throughout. This project will involve the close interfacing between highly quantitative experimental data and state of the art modeling techniques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systems biological assessment of T cell responses to vaccination
  • 批准号:
    10584571
  • 项目类别:
  • 资助金额:
    $37.9万
  • 财政年份:
    2022
  • 负责人:
    Mark Morris Davis
  • 依托单位:
Systems biological assessment of T cell responses to vaccination
  • 批准号:
    10419280
  • 项目类别:
  • 资助金额:
    $30.97万
  • 财政年份:
    2022
  • 负责人:
    Mark Morris Davis
  • 依托单位:
Administrative Core
  • 批准号:
    10190558
  • 项目类别:
  • 资助金额:
    $6.62万
  • 财政年份:
    2021
  • 负责人:
    Mark Morris Davis
  • 依托单位:
Molecular interception and immunological characterization of age-associated disease
  • 批准号:
    10190562
  • 项目类别:
  • 资助金额:
    $63.87万
  • 财政年份:
    2021
  • 负责人:
    Mark Morris Davis
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究